What is the main business of Vitatis?

The main business activity of Vitatis focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 17, 2001.

Where is the headquarters located?

The headquarters is located at: ul. Zeusa 27, 01-497 Warszawa.

What is the share capital?

The share capital of the company is PLN 3,090,000 (approx. $834,684).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What was the revenue?

The company reported a revenue of $140,409 in 2023, which is an increase of 35.8% compared to 2022.

Is the company profitable?

Yes, in 2023 the company was profitable, achieving a net profit of $50,631, meaning the company increased its profit by 100.5%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $60,006 in 2023, representing 72% of all operating expenses.

Vitatissp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2001-08-17

Share capital

3,090,000.00 PLN

Registered address

ul. Zeusa 27, 01-497 Warszawa, Poland

Electronic delivery address

AE:PL-68374-68481-UUTRJ-23

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 507 days for 2018).

2024not filed
202328/03/2025
202204/10/2023
202104/10/2023
202017/02/2022
201903/12/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Industry · Specialist medical practice activities1,819 / 2,430

Top 75%

Division · Human health activities5,913 / 7,730

Top 76%

Sector · Arts, entertainment and recreation activities7,016 / 9,558

Top 73%

Voivodeship · Mazowieckie72,170 / 142,035

Top 51%

Country · Poland260,618 / 495,867

Top 53%

Results vs industry

Revenue

This companyUSD 140.41kMedianUSD 443.52kAverageUSD 1.75m

Net profit

This companyUSD 50.63kMedianUSD 14.31kAverageUSD 129.52k

Operating costs

This companyUSD 83.91kMedianUSD 397.10kAverageUSD 1.56m

Assets

This companyUSD 1.25mMedianUSD 173.92kAverageUSD 1.02m

Industry

Authorized Representatives

Feliks Stanisław Świerkotage 91 – President

Maciej Grzegorz Świerkotage 56 – Attorney-in-fact (sole)

Manner of representation

A member of the management board or a commercial proxy acting individually

Ownership

Owner	Shares	Share value	Stake
Agnieszka Beata Czarnecka-Świerkotage 55	776	$104,808.21	12.5566%
Maciej Grzegorz Świerkotage 56	5,404	$729,875.74	87.4434%

Maciej Grzegorz Świerkot and Agnieszka Beata Czarnecka-Świerkot hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 1994-12-01.

BNP Paribas Bank Polska
07 2030 0045 1110 0000 0087 7150

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Nectar Polskasp. z o.o.	$528,123.00	klinikametoda.pl
Astimedsp. z o.o.	$498,540.18	astimed.pl
I. V. Clinicsp. z o.o.	$510,444.80	ivclinic.com.pl
MAAMsp. z o.o.	$455,593.52	urmed.pl
Saska Medsp. z o.o.	$241,826.45	saskamed.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl
Biocells Medicalsp. z o.o.	$11,508.17	biocellsmedical.com
Bodyclinicsp. z o.o.	$3,758.46	bodyclinic.pl
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl

Change history

Date	Event
2022-12-12	Address change (Bystrzycka 19a, 58-100, Świdnica → Ul. Zeusa 27, 01-497, Warszawa)
2022-12-12	Name change ("sieć Handlowa-Spółka Z Ograniczoną Odpowiedzialnością" → Vitatis)
2001-10-16	Share capital increase (1,920,000.00 PLN → 3,090,000.00 PLN)
2001-08-17	Entered in the register

FAQ

Last updated: 2026-04-01